Skip to main content
Equibles
WRBY logo

WRBY · Warby Parker Inc. · Metrics

Track WRBY — free

Use WRBY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WRBY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$25.63 +0.01 (+0.04%) At close · Oct 21
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.19B
Shares
123.61M
Volume · Oct 21 1.75M Avg daily vol (3M) 2.89M

WRBY metrics

93 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.63
Market cap
$3.19B

Price action

20 metrics
Price change (1W)
+2.8%
Price change (30D)
+11.7%
Price change (3M)
+4.4%
Price change (6M)
+4.3%
Price change (YTD)
+17.6%
Price change (1Y)
+17.9%
Trailing year
Price change (5Y)
-55.3%
52-week high
$30.34
52-week low
$16.49
Change from 52-week high
-15.5%
Change from 52-week low
+55.4%
Annualized volatility
77.7%
Annualized volatility (3M)
64.2%
Beta
2.2
RSI (14D)
51.3
Price vs SMA 50
+1.3%
Price vs SMA 200
+1.5%
Avg volume (3M)
2.89M
Relative volume
0.6
Average dollar volume
$74.02M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
123.61M

Valuation

12 metrics
P / E (TTM)
427.2
Trailing earnings · reciprocal yield 0.2%
PEG ratio
—
EV / revenue
3.2×
reciprocal yield 31.5%
EV / EBITDA
52.6×
reciprocal yield 1.9%
EV / EBIT
1,864.7×
reciprocal yield 0.1%
P / sales
3.5×
reciprocal yield 28.6%
P / book
8.1
reciprocal yield 12.3%
FCF yield
0.7%
TTM · current market cap
Buyback yield
0.0%
P / FCF
146.5
reciprocal yield 0.7%
P / operating cash flow
33.4
reciprocal yield 3.0%
Earnings yield
0.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
54.7%
Operating margin
0.2%
Trailing 12 months
Net margin
0.8%
Gross profit (TTM)
$498.49M
Operating profit (TTM)
$1.55M
Net income (TTM)
$7.74M
Trailing 12 months
Diluted EPS (TTM)
$0.06
FCF margin
2.4%
Effective tax rate
21.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$7.23
Gross profit per diluted share (TTM)
$3.95
Operating profit per diluted share (TTM)
$0.01
EBITDA per diluted share (TTM)
$0.44
Net income per diluted share (TTM)
$0.06
Operating cash flow per diluted share (TTM)
$0.76
Free cash flow per diluted share (TTM)
$0.17
Capital expenditures per diluted share (TTM)
$0.58
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.27
Book value per share
$-3.67

Growth

11 metrics
Revenue growth YoY
+9.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$911.61M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+28.1%

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.0%
Debt / equity
0.0
Current ratio
2.3
EBITDA (TTM)
$55.02M
Free cash flow (TTM)
$21.75M
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
-5.3
Return on invested capital
1.2%
Trailing 12 months
Net cash
$292.67M
Latest balance sheet
Cash & equivalents
$292.67M
Total assets
$772.32M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$95.36M
Capital expenditures (TTM)
$73.61M
R&D (TTM)
—
SG&A (TTM)
$496.94M
Stock compensation (TTM)
$34.60M
R&D / revenue
—
Stock compensation / revenue
3.8%

Ownership (13F)

9 metrics
13F filers
306
13F filer change QoQ
0
Institutional ownership
104.4%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+7.8%
Holder tenure
11.7
Price vs estimated holder cost
+40.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.7%

Short interest

3 metrics
Short interest
14.7%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.18M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1504776 CUSIP 93403J106 13F (30d) 33 filings 33 filers Visit website Investor relations